Kidney and Metabolic Bone Diseases Vol.26 No.4(6)

Theme Parathyroid diseases and their pathogenesis
Title Role of FGF-23-Klotho in hyperparathyroidism
Publish Date 2013/11
Author Kazuhiro Shiizaki Department of Pathology, The University of Texas Southwestern Medical Center at Dallas
Author Makoto Kuro-o Department of Pathology, The University of Texas Southwestern Medical Center at Dallas
[ Summary ] Klotho and FGF-23 play important roles in bone and mineral metabolism including endocrine regulation of phosphate and vitamin D metabolism. CKD-induced adaptation of this endocrine axis may contribute to secondary hyperparathyroidism.
Klotho is essential for FGF-23 signaling as a co-receptor of FGF receptor. Decreased Klotho expression levels in the kidneys may increase circulating FGF-23 levels. FGF-23 suppresses the activation of vitamin D, resulting in secondary hyperparathyroidism. In the early stages of CKD, increased FGF-23 and PTH levels compensate for decreased functional nephron numbers to maintain the homeostasis of phosphate and calcium.
Recent studies have revealed that PTH is also regulated by Klotho and FGF-23. It is proposed that resistance of the parathyroid glands to FGF-23 may contribute to secondary hyperparathyroidism.
back